Literature DB >> 16238454

Adipocytokines and cancer.

D Housa1, J Housová, Z Vernerová, M Haluzík.   

Abstract

Adipose tissue-produced hormones significantly affect the metabolism of lipids and carbohydrates as well as numerous other processes in human body. It is generally accepted that endocrine dysfunction of adipose tissue may represent one of the causal links between obesity and insulin resistance/diabetes. Epidemiological studies underlined that obesity represents a significant risk factor for the development of cancer, although the exact mechanism of this relationship remains to be determined. Multiple recent studies have indicated that some of adipose tissue-derived hormones may significantly influence the growth and proliferation of tumorous stroma and malignant cells within. Here we review current knowledge about possible relationship of leptin and adiponectin to the etiopathogenesis of different malignant tumors. Most of the studies indicated that while leptin may potentiate the growth of cancer cells in vitro, adiponectin appears to have an opposite effect. Further studies are necessary to decide whether obesity-induced endocrine dysfunction of adipose tissue can directly influence carcinogenesis in different tissues and organs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16238454     DOI: 10.33549/physiolres.930848

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  88 in total

1.  Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection.

Authors:  Chao-Hung Hung; Jing-Houng Wang; Tsung-Hui Hu; Chien-Hung Chen; Kuo-Chin Chang; Yi-Hao Yen; Yuan-Hung Kuo; Ming-Chao Tsai; Sheng-Nan Lu; Chuan-Mo Lee
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial.

Authors:  Gerd Bobe; Gwen Murphy; Connie J Rogers; Kenneth W Hance; Paul S Albert; Adeyinka O Laiyemo; Leah B Sansbury; Elaine Lanza; Arthur Schatzkin; Amanda J Cross
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

3.  Physical Activity in the Prevention and Therapy of Breast Cancer.

Authors:  Christine Graf; Nicolas Wessely
Journal:  Breast Care (Basel)       Date:  2010-12-08       Impact factor: 2.860

4.  Adipose Tissue: A Metabolic Regulator. Potential Implications for the Metabolic Outcome of Subjects Born Small for Gestational Age (SGA).

Authors:  Arianna Maiorana; Chiara Del Bianco; Stefano Cianfarani
Journal:  Rev Diabet Stud       Date:  2007-11-10

Review 5.  Insights into the relationships between diabetes, prediabetes, and cancer.

Authors:  Lorenzo Scappaticcio; Maria Ida Maiorino; Giuseppe Bellastella; Dario Giugliano; Katherine Esposito
Journal:  Endocrine       Date:  2016-12-31       Impact factor: 3.633

Review 6.  Obesity, energy balance, and cancer: new opportunities for prevention.

Authors:  Stephen D Hursting; John Digiovanni; Andrew J Dannenberg; Maria Azrad; Derek Leroith; Wendy Demark-Wahnefried; Madhuri Kakarala; Angela Brodie; Nathan A Berger
Journal:  Cancer Prev Res (Phila)       Date:  2012-10-03

7.  Association of leptin, 25-hydroxyvitamin D, and parathyroid hormone in women.

Authors:  Micah Maetani; Gertraud Maskarinec; Adrian A Franke; Robert V Cooney
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

Review 8.  Multifaceted leptin network: the molecular connection between obesity and breast cancer.

Authors:  Neeraj K Saxena; Dipali Sharma
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-11-10       Impact factor: 2.673

9.  Surgical management of gastroesophageal reflux disease in obesity.

Authors:  Sayeed Ikramuddin
Journal:  Dig Dis Sci       Date:  2008-07-29       Impact factor: 3.199

10.  Adiponectin inhibits murine pancreatic cancer growth.

Authors:  Motohiko Kato; Kenji Watabe; Masahiko Tsujii; Tohru Funahashi; Iichiro Shimomura; Tetsuo Takehara
Journal:  Dig Dis Sci       Date:  2014-05-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.